Your Article Summary
See Latest ArticlesPrescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09
Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk.
Methods- Review of evidence for/against statin use in nonalcoholic fatty liver disease
- Statins are widely prescribed, with a significant role in reducing cardiovascular risk
- Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
- Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
- Guidelines advising against statin use in this setting should be reviewed
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of free radicals in liver diseases
Hepatology International, 12/02/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09